Does Cocaine Show Up in a Blood Test?

Cocaine is detectable in a blood test, both as the parent drug and as its breakdown products. The drug itself disappears from blood relatively quickly, with a half-life somewhere between 30 minutes and about 90 minutes depending on the study, but its primary metabolite, benzoylecgonine, lingers far longer and serves as the main target for most screening tests. How long a blood test can catch cocaine use depends on the dose, how often someone uses, and individual biology, but the practical detection window in blood is considerably shorter than in urine.

How Long Cocaine Stays in Your Blood

Cocaine is broken down fast. After a single intravenous or smoked dose, the average half-life of cocaine in blood is roughly 38 to 39 minutes, meaning half the drug is gone from circulation in well under an hour.¹ Other research places the plasma half-life a bit wider, in the range of 30 to 90 minutes.² That range depends partly on how the drug was taken: snorting it produces a slower rise and a slightly longer tail compared with smoking or injecting, which hit the bloodstream almost instantly and decline just as sharply.

What makes blood testing useful past that first hour or two is benzoylecgonine, the main metabolite your liver produces when it breaks cocaine down. Benzoylecgonine has a half-life of roughly four to six hours after a single use.² In practical terms, a blood test can usually pick up benzoylecgonine for about one to two days after a single episode of use. But that estimate shifts dramatically with repeated or heavy use. In a study where volunteers received cocaine orally over multiple days, researchers found a terminal elimination half-life for metabolites ranging from about 15 to 52 hours, far longer than the estimates from single-dose studies.³ The explanation is straightforward: with chronic use, cocaine and its byproducts accumulate in tissues and then trickle back into the bloodstream over an extended period. Someone who uses heavily can test positive in blood for several days after their last dose, while a one-time user would typically clear below detectable levels much sooner.

What a Blood Test Actually Looks For

Most drug screening panels that include cocaine target benzoylecgonine rather than cocaine itself, because benzoylecgonine is present in higher concentrations and sticks around longer. In a controlled nasal-dose study, peak concentrations of cocaine in whole blood were around 344 ng/mL, while benzoylecgonine peaked at about 371 ng/mL and stayed elevated well after cocaine had dropped off.⁴ A second metabolite, ecgonine methyl ester, also appears but at lower concentrations.

The type of test matters. Initial screening in clinical or workplace settings typically uses an immunoassay, an antibody-based test that flags whether a sample exceeds a set concentration threshold. These are fast and cheap but can occasionally produce false results. When a positive screen needs verification, labs turn to confirmatory testing using instruments that identify compounds by their chemical fingerprint. Modern methods can simultaneously screen for cocaine and its metabolites alongside dozens or even hundreds of other substances in a very small blood sample, sometimes as little as 100 microliters, with detection limits as low as a fraction of a nanogram per milliliter.⁵ That level of sensitivity means even trace amounts of benzoylecgonine left over from use days earlier can be identified.

One practical detail from the research: cocaine distributes almost evenly between the liquid portion of blood (plasma) and the cells (whole blood). The whole-blood-to-plasma ratio sits close to 1 for both cocaine and benzoylecgonine.⁴ So whether a lab analyzes your serum, plasma, or whole blood, the concentration readings will be broadly comparable.

When Alcohol Is Involved, a Third Marker Appears

Cocaine and alcohol are frequently used together, and that combination creates a unique substance in the body called cocaethylene. Your liver produces cocaethylene only when cocaine and ethanol are present at the same time. Roughly 17% of the cocaine dose gets converted to cocaethylene under those conditions.⁶ Cocaethylene is pharmacologically active, meaning it produces its own stimulant and cardiovascular effects on top of what cocaine alone does. It also has a longer half-life than cocaine, so it hangs around in the blood after cocaine has been cleared.

For testing purposes, cocaethylene is significant because it acts as a direct biological indicator that someone used cocaine and drank alcohol simultaneously. In one emergency department study, about 60% of patients who tested positive for cocaine also had detectable cocaethylene in their plasma, and the vast majority of those also had ethanol on board.⁷ Specialized blood-spot techniques have been developed specifically to detect cocaine, benzoylecgonine, and cocaethylene together, giving a clearer picture of exactly what was consumed.⁸ Standard workplace or clinical screening panels do not always test for cocaethylene specifically, but forensic and advanced clinical labs can and do look for it when the circumstances call for it.

Why Some People Clear Cocaine Faster Than Others

The speed at which your body breaks down cocaine is not a fixed number. One of the most important variables is the level of an enzyme called butyrylcholinesterase in your blood. This enzyme acts as the primary workhorse for converting cocaine into ecgonine methyl ester, a harmless byproduct.⁹ People naturally vary in how much of this enzyme they carry, and that variation has a dramatic effect on how long cocaine lasts in their system.

Lab experiments have demonstrated the relationship clearly: at low enzyme concentrations, cocaine’s half-life in plasma was about 116 minutes, but when enzyme levels were raised to roughly twelve times that concentration, the half-life dropped to just nine minutes.¹⁰ That is a thirteenfold difference in clearance speed driven entirely by one enzyme. People with genetically low levels of this enzyme break cocaine down more slowly, remain exposed to its effects longer, and would test positive in blood for a longer window. They may also face greater toxicity risk because, when the primary enzyme pathway is sluggish, a larger share of cocaine gets processed by a secondary liver enzyme that produces norcocaine, which is itself toxic.⁹

Other factors influence clearance too. Liver health matters, since the liver handles a major share of cocaine metabolism. Body mass, hydration, and the presence of other drugs all play roles. But the enzyme variability is probably the single biggest source of person-to-person differences that most people have never heard of.

False Positives on Cocaine Screens

Immunoassay-based cocaine screens are generally considered reliable, but false positives do happen. A study at a transplant center found that among patients being screened before kidney transplant, about 61% of positive cocaine screens turned out to be false positives on confirmatory testing. That rate was significantly higher than the roughly 22% false-positive rate in a comparison group of general hospital patients.¹¹ The researchers could not identify a specific medication or substance responsible for the elevated false-positive rate in those pre-transplant patients, which makes the finding somewhat unsettling for anyone in that population.

The overall false-positive rate for cocaine immunoassays tends to be low in the general population. But the transplant study is a useful reminder that a positive initial screen is not the final word. If a positive result has real consequences, whether for employment, legal proceedings, or medical decisions, confirmation testing should follow. Confirmation methods that identify the precise chemical structure of benzoylecgonine are essentially immune to cross-reactivity problems, so a confirmed positive is highly reliable.

Blood Testing Compared With Urine and Oral Fluid

Blood is not the most common specimen used for cocaine screening. Urine testing is far more widespread, especially in workplaces and clinical settings, mainly because urine collection is noninvasive and the detection window is longer. Benzoylecgonine can be found in urine for roughly two to four days after a single use, and potentially much longer in chronic users, since the kidneys continue excreting metabolites well after blood levels have dropped below detection.

Blood testing has its own advantages, though. A positive blood test, especially one that finds cocaine itself rather than just the metabolite, suggests relatively recent use, typically within hours. That makes blood the preferred specimen in certain situations: emergency medicine, driving-under-the-influence investigations, and forensic cases where timing matters. A urine test tells you someone used cocaine recently, but it cannot distinguish between use three hours ago and use three days ago. A blood test gives you a better sense of when.

Oral fluid (saliva) has become increasingly popular for roadside and workplace testing because it is easy to collect and, like blood, it tends to reflect more recent use. A large national survey of nighttime drivers found that oral fluid and blood gave very similar information about recent drug use, and for cocaine specifically, oral fluid actually caught slightly more positives than blood did.¹² The likely reason is that cocaine concentrates in saliva relative to blood, so oral fluid can pick up lower-level exposure that blood might miss. For someone wondering whether their cocaine use will show up, the answer is that any common specimen type, whether blood, urine, or saliva, can detect it. The question is really about how far back each one can reach.

Why Sample Handling Matters More Than You Would Think

Cocaine is chemically unstable in biological samples. Once blood is drawn, enzymes in the sample continue breaking cocaine down inside the tube. If the specimen is not handled properly, cocaine concentrations can drop substantially between collection and analysis, potentially leading to an underestimate of what was actually in the person’s blood at the time of the draw.

The standard solution is sodium fluoride, a preservative that inhibits the enzymes responsible for this breakdown. Blood collected into tubes containing sodium fluoride retained 86 to 91% of its cocaine concentration after 48 hours, regardless of whether the tube was refrigerated. Without sodium fluoride, cocaine degraded substantially even when the sample was kept cold.¹³ Standard gray-top blood collection tubes, which contain sodium fluoride and potassium oxalate, are the recommended container for cocaine blood testing.

For longer-term storage, temperature becomes critical. One study tracked cocaine and its metabolites in blood over a full year and found that freezing at minus 20°C kept all four measured compounds stable, with recoveries above 80%. Refrigeration at 4°C was much worse: cocaine and cocaethylene disappeared entirely within 30 days in samples without sodium fluoride, and within about 150 days even with the preservative added.¹⁴ Benzoylecgonine held up better because it is the end product of the breakdown, not its victim, but even it degraded significantly at refrigerator temperature without preservative. For legal or forensic cases where a blood sample might sit in storage for months before retesting, these details are not trivial. A poorly stored sample can give a misleadingly low result.

Passive Exposure and Secondhand Smoke

A common concern is whether being around someone who is smoking crack cocaine could cause a positive blood test. The evidence suggests it would not. In a controlled study of passive inhalation, blood specimens collected from subjects immediately after exposure to cocaine smoke were negative for both cocaine and its metabolites.¹⁵ Urine tests in passive-exposure studies have occasionally picked up trace amounts of benzoylecgonine, but even those results typically fall below standard cutoff thresholds used in workplace testing. Blood, with its shorter detection window and higher practical thresholds, is even less likely to register secondhand exposure.

This is a meaningful distinction for people who worry about environmental contamination. While trace amounts of cocaine can be found on paper currency, countertops, and other surfaces, the quantities involved are orders of magnitude below what would produce a detectable concentration in a blood sample. The “I was just in the same room” defense does not hold up when blood is the specimen, and the research backs that up.

Postmortem Blood Testing and Its Complications

In forensic pathology, cocaine blood testing takes on additional complexity. After death, drug concentrations in blood change. Cocaine and its metabolites can shift between body compartments as cell membranes break down, a process called postmortem redistribution. Research comparing cocaine levels in blood drawn from different sites, such as the heart versus the leg, found substantial variability between individuals in both the direction and magnitude of concentration changes after death.¹⁶ One metabolite, ecgonine methyl ester, showed significant increases over the first eight hours postmortem at certain collection sites.

A large Dutch review of 148 postmortem cases analyzed cocaine, benzoylecgonine, and ecgonine methyl ester in both central (heart) and peripheral (leg) blood, specifically to understand how these ratios vary.¹⁷ The upshot of this research is that interpreting postmortem cocaine blood levels requires caution. A number from a postmortem blood draw does not straightforwardly translate to what was circulating at the time of death. Forensic toxicologists account for the collection site, the time between death and sample collection, and the ratios between parent drug and metabolites when drawing conclusions.

Testing in Newborns and Prenatal Exposure

When prenatal cocaine exposure is suspected, clinicians can test the newborn’s blood, but they more commonly turn to other specimens like meconium (the baby’s first stool) or umbilical cord tissue, which accumulate drug metabolites over a longer period of fetal development and therefore offer a wider detection window. A study comparing umbilical cord tissue to meconium for detecting fetal drug exposure found 99.2% concordance for cocaine between the two specimen types.¹⁸ Cord tissue has the practical advantage of being available immediately at delivery, whereas meconium can take a day or two to pass.

Neonatal blood testing can confirm very recent maternal cocaine use near the time of delivery, since cocaine and benzoylecgonine cross the placenta. But for identifying exposure that occurred weeks or months earlier during pregnancy, blood alone is insufficient, and the alternative specimen types are preferred. This is one context where blood’s short detection window works against it, and where understanding what each specimen type can and cannot tell you directly affects clinical decision-making.